A human arterial transcriptomic signature predicts major adverse cardiac events and identifies novel, redox-related therapeutic targets within the vascular wall

Authors: C P Kotanidis, H Lockstone, M Polkinghorne, I Badi, I Akoumianakis, M Siddique, A Antonopoulos, T Evans, S Farid, V Srivastava, G Krasopoulos, R Sayeed, K M Channon, C Antoniades

Published: 2021-10-20

DOI: 10.1093/eurheartj/ehab724.1089

Source: Full article


Abstract

Abstract